JP2006528667A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528667A5 JP2006528667A5 JP2006529795A JP2006529795A JP2006528667A5 JP 2006528667 A5 JP2006528667 A5 JP 2006528667A5 JP 2006529795 A JP2006529795 A JP 2006529795A JP 2006529795 A JP2006529795 A JP 2006529795A JP 2006528667 A5 JP2006528667 A5 JP 2006528667A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- optionally substituted
- group
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0310962A GB0310962D0 (en) | 2003-05-13 | 2003-05-13 | Novel compounds |
| GB0407391A GB0407391D0 (en) | 2004-03-31 | 2004-03-31 | Novel compounds |
| PCT/EP2004/005083 WO2004101587A1 (en) | 2003-05-13 | 2004-05-11 | Novel 14 and 15 memberred-ring compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528667A JP2006528667A (ja) | 2006-12-21 |
| JP2006528667A5 true JP2006528667A5 (enExample) | 2007-07-05 |
Family
ID=33454579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529795A Pending JP2006528667A (ja) | 2003-05-13 | 2004-05-11 | 新規１４−及び１５−員環化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070293472A1 (enExample) |
| EP (1) | EP1628989B1 (enExample) |
| JP (1) | JP2006528667A (enExample) |
| AR (1) | AR044304A1 (enExample) |
| AT (1) | ATE348837T1 (enExample) |
| CA (1) | CA2525455A1 (enExample) |
| CL (1) | CL2004001012A1 (enExample) |
| DE (1) | DE602004003809T2 (enExample) |
| DK (1) | DK1628989T3 (enExample) |
| ES (1) | ES2278319T3 (enExample) |
| HR (1) | HRP20070094T3 (enExample) |
| PL (1) | PL1628989T3 (enExample) |
| PT (1) | PT1628989E (enExample) |
| SI (1) | SI1628989T1 (enExample) |
| WO (1) | WO2004101587A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
| AU2005240849B2 (en) * | 2004-05-06 | 2008-10-23 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Ester linked macrolides useful for the treatment of microbial infections |
| GB0424961D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| WO2007054295A1 (en) * | 2005-11-09 | 2007-05-18 | Glaxo Group Limited | New 4*-substituted erythromycin derivative |
| GB0424958D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| JP2008540503A (ja) | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用なエーテル結合マクロライド |
| WO2007054296A1 (en) * | 2005-11-09 | 2007-05-18 | Glaxo Group Limited | Macrolones |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| BR112012029586A2 (pt) * | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos |
| KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4180654A (en) * | 1978-01-03 | 1979-12-25 | Pfizer Inc. | 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate |
| US4512982A (en) * | 1984-04-13 | 1985-04-23 | Pfizer Inc. | 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method |
| US4686207A (en) * | 1985-11-12 | 1987-08-11 | Abbott Laboratories | Erythromycin A 11,12-carbonates and method of use |
| IL93936A (en) * | 1989-03-28 | 1994-06-24 | Abbott Lab | History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them |
| WO1996034007A1 (es) * | 1995-04-27 | 1996-10-31 | Laboratorios Aranda, S.A. De C.V. | Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen |
| DE69723848T2 (de) * | 1996-05-07 | 2004-07-01 | Abbott Laboratories, Abbott Park | 3-descladinose-2,3-anhydroerythromycin-derivate |
| EP0895999A1 (en) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
| GB0025688D0 (en) * | 2000-10-19 | 2000-12-06 | Glaxo Group Ltd | Macrolides |
| JP4311203B2 (ja) * | 2001-08-08 | 2009-08-12 | 大正製薬株式会社 | １１ａ−アザライド化合物及びその製造方法 |
| GB0127349D0 (en) * | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
| GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
-
2004
- 2004-05-11 EP EP04732108A patent/EP1628989B1/en not_active Expired - Lifetime
- 2004-05-11 US US10/556,708 patent/US20070293472A1/en not_active Abandoned
- 2004-05-11 WO PCT/EP2004/005083 patent/WO2004101587A1/en not_active Ceased
- 2004-05-11 DE DE602004003809T patent/DE602004003809T2/de not_active Expired - Fee Related
- 2004-05-11 CA CA002525455A patent/CA2525455A1/en not_active Abandoned
- 2004-05-11 AR ARP040101609A patent/AR044304A1/es not_active Application Discontinuation
- 2004-05-11 PT PT04732108T patent/PT1628989E/pt unknown
- 2004-05-11 PL PL04732108T patent/PL1628989T3/pl unknown
- 2004-05-11 ES ES04732108T patent/ES2278319T3/es not_active Expired - Lifetime
- 2004-05-11 DK DK04732108T patent/DK1628989T3/da active
- 2004-05-11 AT AT04732108T patent/ATE348837T1/de not_active IP Right Cessation
- 2004-05-11 SI SI200430216T patent/SI1628989T1/sl unknown
- 2004-05-11 HR HR20070094T patent/HRP20070094T3/xx unknown
- 2004-05-11 JP JP2006529795A patent/JP2006528667A/ja active Pending
- 2004-05-11 CL CL200401012A patent/CL2004001012A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024524766A5 (enExample) | ||
| JP2021534124A5 (enExample) | ||
| EP3704091B1 (en) | INTEGRATED STRESS RESPONSE PATH MODULATORS | |
| JP2010500293A5 (enExample) | ||
| JP2013532652A5 (enExample) | ||
| JP2005519932A5 (enExample) | ||
| JP2005508960A5 (enExample) | ||
| JP2009507909A5 (enExample) | ||
| JP2005505618A5 (enExample) | ||
| RU2007109598A (ru) | Кристаллическая форма бифенильного соединения | |
| JP2002513793A5 (enExample) | ||
| JP2004529114A5 (enExample) | ||
| JP2006501201A5 (enExample) | ||
| JP2004523478A5 (enExample) | ||
| WO2015000431A1 (zh) | 替唑尼特氨基甲酸酯及其在药学中的应用 | |
| JP2019535813A5 (enExample) | ||
| RU2007121581A (ru) | Макролоны-аминозамещенные хинолоны | |
| JP2009520695A5 (enExample) | ||
| JP2005519885A5 (enExample) | ||
| JP2008519788A5 (enExample) | ||
| JP2007536371A5 (enExample) | ||
| JP2004525178A5 (enExample) | ||
| JP2004521150A5 (enExample) | ||
| JP2005502636A5 (enExample) | ||
| JP2015534567A5 (enExample) |